Application segmentation of the Medical Intelligent System market delineates the functional domains where AI‑driven solutions are deployed. The primary diagnostic segment, accounting for roughly 30 % of market revenue, encompasses image analysis, pathology automation, and predictive screening tools that augment clinical decision‑making. The therapeutic segment, estimated at 25 %, includes treatment planning systems, robotic surgery assistants, and personalized drug‑dosage algorithms that directly influence patient outcomes. Monitoring applications, representing about 20 %, cover remote patient surveillance, vital‑sign analytics, and chronic‑disease management platforms that generate continuous data streams for early intervention. Administrative solutions, contributing 15 %, automate scheduling, claims processing, and resource allocation, thereby reducing operational overhead. Finally, the research segment, at 10 %, provides data‑mining and clinical‑trial optimization tools that accelerate discovery pipelines. Collectively, this Medical Intelligent System segmentation by application clarifies how each functional niche drives overall market size and informs investment prioritization.